Sort   by:  
 Page size 
UnknownSecondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.
Not available
S-EPMC4895174 | biostudies-literature
UnknownDefining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.
Not available
S-EPMC5940636 | biostudies-literature
UnknownYounger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV.
Not available
S-EPMC3889634 | biostudies-literature
UnknownImpact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.
Not available
S-EPMC4574015 | biostudies-literature
UnknownOlder patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
Not available
S-EPMC4050299 | biostudies-literature
Sort   by:  
 Page size